uniQure N.V. (QURE)
NASDAQ · Manufacturing · Pharmaceutical preparations
$38.30−$0.0200 (−0.05%) on the dayAs of the close; data may be delayed.
QURE price, last 12 months
Key stats
- Previous close
- $38.32
- Open
- $38.51
- Day range
- $37.62 – $39.12
- 52-week range
- $8.73 – $71.50
- Volume
- 1.1M
- Avg volume (20 days)
- 1.4M
- Market cap
- $2.7B
Performance
1W−13.0%
1M−24.8%
3M−19.4%
6M+145.5%
YTD+60.1%
1Y−19.4%
vs S&P 500, 1Y−36.2 pts
Technicals and fundamentals
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.7B